Suppr超能文献

利用降解抑制剂 auxinole 生成条件性生长素诱导降解结构域(AID)细胞,并对融合了降解结构域的蛋白质进行严格控制。

Generation of conditional auxin-inducible degron (AID) cells and tight control of degron-fused proteins using the degradation inhibitor auxinole.

机构信息

Department of Chromosome Science, National Institute of Genetics, Research Organization of Information and Systems (ROIS), Yata 1111, Mishima, Shizuoka 411-8540, Japan; Department of Genetics, The Graduate University for Advanced Studies (SOKENDAI), Yata 1111, Mishima, Shizuoka 411-8540, Japan.

Department of Biochemistry, Okayama University of Science, Okayama 700-0005, Japan.

出版信息

Methods. 2019 Jul 15;164-165:73-80. doi: 10.1016/j.ymeth.2019.04.010. Epub 2019 Apr 24.

Abstract

Controlling protein expression using a degron is advantageous because the protein of interest can be rapidly depleted in a reversible manner. We pioneered the development of the auxin-inducible degron (AID) technology by transplanting a plant-specific degradation pathway to non-plant cells. In human cells expressing an E3 ligase component, OsTIR1, it is possible to degrade a degron-fused protein with a half-life of 15-45 min in the presence of the phytohormone auxin. We reported previously the generation of human HCT116 mutants in which the C terminus of endogenous proteins was fused with the degron by CRISPR-Cas9-based knock-in. Here, we show new plasmids for N-terminal tagging and describe a detailed protocol for the generation of AID mutants of human HCT116 and DLD1 cells. Moreover, we report the use of an OsTIR1 inhibitor, auxinole, to suppress leaky degradation of degron-fused proteins. The addition of auxinole is also useful for rapid re-expression after depletion of degron-fused proteins. These improvements enhance the utility of AID technology for studying protein function in living human cells.

摘要

利用降解结构域来控制蛋白质表达是有利的,因为目标蛋白质可以以可逆的方式快速耗尽。我们通过将植物特有的降解途径移植到非植物细胞中,率先开发了吲哚乙酸诱导的降解结构域(AID)技术。在表达 E3 连接酶成分 OsTIR1 的人细胞中,在植物激素生长素的存在下,融合了降解结构域的蛋白质的半衰期可以达到 15-45 分钟。我们之前曾报道过通过 CRISPR-Cas9 基于基因敲入的方法,将内源性蛋白质的 C 末端与人 HCT116 突变体融合的降解结构域。在这里,我们展示了用于 N 端标记的新质粒,并描述了用于生成人 HCT116 和 DLD1 细胞的 AID 突变体的详细方案。此外,我们还报告了使用 OsTIR1 抑制剂 auxinole 来抑制降解结构域融合蛋白的漏失性降解。在耗尽降解结构域融合蛋白后添加 auxinole 也有助于快速重新表达。这些改进增强了 AID 技术在研究活体细胞中蛋白质功能方面的实用性。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验